RNA5SP67

Across TCGA pan-cancer cohorts, RNA5SP67 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNA5SP67 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RNA5SP67 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP67 expression acts as an unfavorable survival marker, although some lineages such as ESCA and PAAD show a favorable association.

UVM, ESCA, and PAAD are the cancer types where RNA5SP67 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.136	0.919	<.001	90	view →
ESCA	OS	Median	III,IV	0.629	0.309	.002	36	view →
PAAD	OS	Tertile	II,III,IV	0.606	0.318	.010	30	view →
LUAD	OS	Tertile	All	0.492	0.306	.015	21	view →
SKCM	OS	Tertile	II,III,IV	0.578	0.765	.003	18	view →
KIRC	DFS	Median	IV	0.803	0.447	.006	14	view →
LGG	DFS	Tertile	All	0.213	0.472	<.001	9	view →
CHOL	OS	Tertile	All	0.345	0.740	.017	4	view →
SARC	DFS	Tertile	All	0.379	0.608	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNA5SP67–UVM (OS)

Open the UVM breakdown →